Where does Pulmonx Corporation rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Pulmonx Corporation ranks #6,829 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Pulmonx Corporation hold?

Pulmonx Corporation holds 49 US utility patents granted between 2015 and 2025, spanning 13 technology areas.

What is Pulmonx Corporation's Innovation Score?

Pulmonx Corporation has an Innovation Score of 41.4 out of 100 (top 33% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Pulmonx Corporation focus on?

Pulmonx Corporation's top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 46 patents, ranking #412 of 7,127 assignees active in that subclass. Grants appear in 13 CPC subclasses total.

Is Pulmonx Corporation's patent grant rate increasing or decreasing?

Pulmonx Corporation's recent grant velocity is +19% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Pulmonx Corporation's patents?

Pulmonx Corporation's patents average 12.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Pulmonx Corporation patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Pulmonx Corporation

USPTO PatentsView assignee record - 49 granted patents across 13 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Pulmonx ranks #6,829 of 49,997 tracked US assignees by granted-patent volume, with 49 patents across 13 technology areas.

#6,829
of 49,997 US assignees by volume: Top 33%
by Innovation Score (41.4/100): 12.7
avg claims per patent: +19%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R6829 · US Corporation #6,829 · 49 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-UP · BOOK-FULL

GRANTS-SMALL 49 grants
UPPER-Q #6,829/49,997
PHOTO-FINISH Pelco
CPC-FOCUS A61B · 13 areas
INNOV-PAR 41.4/100
CLAIMS-RICH 12.7 claims/avg
TYPE-USCORP US Corporation
VEL-UP +19% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Pelco, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Pulmonx’s 41.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 13.5 pts (33%) Velocity 7.5 pts (18%) Breadth 12.7 pts (31%) Claim depth 7.6 pts (18%)

Qualcomm Incorporated · highest

85
Global Life… · near

41
Huawei International… · near

41
NeoPhotonics · near

41
Nippon Steel Nisshin · near

41
Pulmonx · this assignee

41
3D Lighting… · lowest

7

What this shows Pulmonx's Innovation Score is 41.4/100 (top 33% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Pulmonx?

Each dot is one of Pulmonx’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Pulmonx’s own 12.7 claims/patent is at or below the 17.6 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Pulmonx vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Pulmonx's grants concentrate

Pulmonx Corporation is a focused PatentsView assignee: 13 CPC subclasses with 93.9% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2019 (9 grants) versus a trough of 2 in 2017. By volume, Pulmonx sits between Pelco, Inc. and Relievant Medsystems, Inc..

Pulmonx's three-year grant acceleration

Pulmonx Corporation shows 18 grants in 2022–2024 against only 16 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Pelco

49
Pixelworks

49
Picarro

49
Principia Biophar…

49
Qliktech Internat…

49
Reata Pharmaceuti…

49
Rimowa

49
Relievant Medsyst…

49
Pulmonx ◀

49

What this shows Pulmonx holds 49 patents at rank #6,829, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Pulmonx

By rank, the assignees closest to #6,829 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Pulmonx's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Pulmonx, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Pulmonx ranks #412 of 7,127 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (41 here).

Nippon Steel Nisshin Co., Ltd. 41 Huawei International Pte. Ltd. 41 NeoPhotonics Corporation 41 Global Life Sciences Solutions Operations UK Limited 41

Pulmonx's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

41 Top 33% higher than 67% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Pulmonx Corporation patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	4	8.2%
2016	3	6.1%
2017	2	4.1%
2018	3	6.1%
2019	9	18.4%
2020	5	10.2%
2021	2	4.1%
2022	6	12.2%
2023	3	6.1%
2024	9	18.4%
2025partial year	3	6.1%

Which technologies does Pulmonx Corporation patent most?

A61B - DIAGNOSIS; SURGERY; Identification 46

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 31

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 22

B65B - Machines, Apparatus OR Devices FOR, OR Methods OF, Packaging Articles OR MATERIALS; Unpacking 5

Y10T - Technical Subjects Covered BY Former US Classification 5

G06T - Image Data Processing OR Generation, IN General 3

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 3

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 3

B21F - Working OR Processing OF Metal Wire 2

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 1

C08F - Macromolecular Compounds Obtained BY Reactions Only Involving Carbon-to-carbon Unsaturated Bonds 1

C08J - WORKING-UP; General Processes OF COMPOUNDING; After-treatment NOT Covered BY Subclasses C08b, C08c, C08f, C08g or C08h 1

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 1

Top 13 of 13 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Pulmonx Corporation's patent record in context - here's where to go next.

Pulmonx Corporation's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 93.9% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #6,829 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Pulmonx Corporation against Pelco, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 41.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.